Exploiting the tumor immune microenvironment and immunometabolism using mitochondria‐targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research-Reference-Cited by-同舟云学术

Exploiting the tumor immune microenvironment and immunometabolism using mitochondria‐targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research

Published:2022-03-02 Issue:4 Volume:36 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Kalyanaraman Balaraman¹²^ORCID

Affiliation:

1. Department of Biophysics Medical College of Wisconsin Milwaukee Wisconsin USA

2. Center for Disease Prevention Research Medical College of Wisconsin Milwaukee Wisconsin USA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202101862R

Reference98 articles.

1. Mechanisms Controlling PD-L1 Expression in Cancer

2. PD‐1/PD‐L1 pathway: current researches in cancer;Han Y;Am J Cancer Res,2020

3. Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death

4. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells

5. Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and trend of mitochondrial research in lung cancer: A bibliometric and visualization analysis;Heliyon;2024-08

2. Exploring the mystery of tumor metabolism: Warburg effect and mitochondrial metabolism fighting side by side;Cellular Signalling;2024-08

3. Decoding mitochondria's role in immunity and cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

4. TPP-based conjugates: potential targeting ligands;Drug Discovery Today;2024-06

5. Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease;Frontiers in Endocrinology;2024-03-21